NEW YORK (GenomeWeb) – To help accelerate the clinical translation of insights gained from genome-wide association studies (GWAS) in type I diabetes, the National Institutes of Health this month announced that it has earmarked $15 million to fund efforts to characterize and validate genetic variations associated with the disease.

While a number of environmental factors play a role in the development of type I diabetes, a number of studies have also implicated genetics in the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sponsored by

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.